Y-mAbs Therapeutics Inc. (YMAB)
4.67
-0.13 (-2.71%)
At close: Apr 03, 2025, 3:59 PM
4.65
-0.35%
Pre-market: Apr 04, 2025, 05:14 AM EDT
Y-mAbs Therapeutics Revenue
Y-mAbs Therapeutics reported an annual revenue of $87.69M, reflecting a 3.38% growth. For the quarter ending December 31, 2024, Y-mAbs Therapeutics generated $26.5M in revenue.
Revenue (ttm)
$87.69M
Revenue Growth
3.38%
Price / Sales Ratio
3.96
Revenue / Employee
$843.13K
Employees
104
Market Cap
210.94M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 87.69M | +3.38% |
| Dec 31, 2023 | 84.82M | +29.96% |
| Dec 31, 2022 | 65.27M | +87.03% |
| Dec 31, 2021 | 34.9M | +68.18% |
| Dec 31, 2020 | 20.75M | n/a |